Development and validation of a risk prediction model for overall survival in cervical cancer patients under 50: a prospective cohort study in southwest China
PeerJ · 2026
DOI: 10.7717/peerj.20509 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift PeerJ, 2026. Verfasst von Li Yuan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing University Cancer Hospital, ChongQing University, Chongqing, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Nomograms. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
Accurately predicting the prognosis of cervical cancer in younger patients is increasingly important due to the rising incidence of the disease in China and the growing number of cases among individuals under 50. This study aimed to develop a nomogram to predict overall survival (OS) in cervical cancer patients under 50 in southwest China.
Methods
Clinicopathological and follow-up data for cervical cancer patients under 50 were prospectively collected as part of an ongoing longitudinal cohort study at Chongqing University Cancer Hospital between January 1, 2015, and May 31, 2019. A training cohort ( n = 703) and a validation cohort ( n = 301) were randomly selected. Variables associated with OS were assessed using a Cox regression model. Multivariate analysis was used to construct the nomogram and identify independent prognostic factors. The model’s performance was evaluated using decision curve analysis (DCA), calibration curves, area under the receiver operating characteristic curve (AUC-ROC), and the concordance index.
Results
The final model identified pathology, International Federation of Gynecology and Obstetrics (FIGO) staging, treatment, β2-microglobulin, neutrophil-lymphocyte ratio (NLR), and albumin as independent risk factors for OS in patients under 50. The concordance index for OS was 0.818 in the training cohort and 0.747 in the validation cohort. Calibration curves in both cohorts showed strong agreement between predicted and observed survival probabilities. In the training cohort, AUCs for 1-, 3-, and 5-year OS were 0.851, 0.847, and 0.816, respectively; in the validation cohort, they were 0.810, 0.733, and 0.730. Compared to the FIGO staging system, the nomogram demonstrated superior predictive accuracy and net benefit, as shown by the net reclassification index (NRI) and DCA.
Conclusion
The nomogram provides a reliable tool for predicting overall survival in cervical cancer patients under 50, supporting more personalized treatment planning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chongqing University Cancer Hospital, ChongQing University, Chongqing, China.
- Chongqing Cancer Multi-omics Big Data Application Engineering Research Center, Chongqing University Cancer Hospital, Chongqing, China.
Zitieren
APA
Yuan, L., Wen, B., Li, X., Liu, F., Lei, H., & Zhou, Q. (2026). Development and validation of a risk prediction model for overall survival in cervical cancer patients under 50: a prospective cohort study in southwest China. PeerJ. https://doi.org/10.7717/peerj.20509
Vancouver
Yuan L, Wen B, Li X, Liu F, Lei H, Zhou Q. Development and validation of a risk prediction model for overall survival in cervical cancer patients under 50: a prospective cohort study in southwest China. PeerJ. 2026. doi:10.7717/peerj.20509
BibTeX
@article{Yuan2026,
author = {Yuan, Li and Wen, Baogang and Li, Xiuying and Liu, Fangrong and Lei, Haike and Zhou, Qi},
title = {Development and validation of a risk prediction model for overall survival in cervical cancer patients under 50: a prospective cohort study in southwest China},
journal = {PeerJ},
year = {2026},
doi = {10.7717/peerj.20509}
}
EUVIMED